Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 5.87 is 17% below its 5-year average of 7.09, around the middle of its 5-year range (1.33–15.62).
As of the fiscal period ended Tuesday, June 30, 2026. 25.49% above its 12-month average of 4.68.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.87.
CURRENT RATIO
5.87
CURRENT RATIO AVG TTM
4.68
CURRENT RATIO AVG 3Y
4.85
CURRENT RATIO AVG 5Y
7.09
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+25.49%
CURRENT VS 3Y AVG
+21.03%
CURRENT VS 5Y AVG
-17.26%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.54
median of 732 covered companies
CURRENT VS SECTOR MEDIAN
+65.57%
vs the sector median at left
Market Cap
$242.92M
Current Ratio
1.54
TTM Avg
1.17
3Y Avg
19.33
5Y Avg
29.22
Market Cap
$243.44M
Current Ratio
3.87
TTM Avg
3.17
3Y Avg
2.70
5Y Avg
2.15
Market Cap
$243.01M
Current Ratio
0.10
TTM Avg
1.46
3Y Avg
1.56
5Y Avg
2.73
Market Cap
$244.33M
Current Ratio
10.14
TTM Avg
15.36
3Y Avg
19.42
5Y Avg
27.25
Market Cap
$240.09M
Current Ratio
1.43
TTM Avg
1.27
3Y Avg
1.29
5Y Avg
1.36
Market Cap
$239.10M
Current Ratio
4.70
TTM Avg
7.13
3Y Avg
7.51
5Y Avg
5.68
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Invivyd, Inc. (IVVD) | $244.82M | 5.87 | 4.68 | 4.85 | 7.09 |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $242.92M | 1.54 | 1.17 | 19.33 | 29.22 |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.44M | 3.87 | 3.17 | 2.70 | 2.15 |
| Galectin Therapeutics Inc. (GALT)vs › | $243.01M | 0.10 | 1.46 | 1.56 | 2.73 |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $244.33M | 10.14 | 15.36 | 19.42 | 27.25 |
| Q32 Bio Inc. (QTTB)vs › | $245.55M | 20.30 | 4.91 | 4.89 | 6.73 |
| InflaRx N.V. (IFRX)vs › | $239.40M | 8.22 | 4.59 | 5.79 | 6.14 |
| Akebia Therapeutics, Inc. (AKBA)vs › | $240.09M | 1.43 | 1.27 | 1.29 | 1.36 |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $239.10M | 4.70 | 7.13 | 7.51 | 5.68 |
| Quantum-Si incorporated (QSI)vs › | $245.30M | 9.97 | 9.81 | 16.34 | 20.09 |
Current Ratio
5.87
Quick Ratio
5.86
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 5.87 |
| 2026-03-31 | 6.47 |
| 2025-12-31 | 7.24 |
| 2025-09-30 | 2.47 |
| 2025-06-30 | 1.33 |
| 2025-03-31 | 1.53 |
| 2024-12-31 | 1.62 |
| 2024-09-30 | 1.92 |
| 2024-06-30 | 4.71 |
| 2024-03-31 | 5.77 |
| 2023-12-31 | 4.47 |
| 2023-09-30 | 10.08 |
| 2023-06-30 | 9.54 |
| 2023-03-31 | 15.62 |
| 2022-12-31 | 15.06 |
| 2022-09-30 | 9.14 |
| 2022-06-30 | 7.09 |
| 2022-03-31 | 5.80 |
| 2021-12-31 | 9.94 |
| 2021-09-30 | 12.82 |
| 2021-06-30 | 10.45 |
| 2021-03-31 | 3.31 |
| 2020-12-31 | 8.98 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
